Advertisement

Topics

Ultragenyx Pharmaceutical Inc RARE Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

22:35 EST 8 Nov 2018 | BioPortfolio Reports

Summary


Ultragenyx Pharmaceutical Inc Ultragenyx is a biotechnology company that develops lifeenhancing therapeutics for rare and ultrarare genetic diseases. Its only marketed product, Mepsevii vestronidase alfa is the first indication approved for the treatment of adults and children with Mucopolysaccharidosis MPS VII Sly syndrome. The company's pipeline comprises Burosumab KRN23 or UX023, a fully human monoclonal antibody in Phase 3 for the treatment of Xlinked hypophosphatemia XLH; and Burosumab in Phase 2 for the treatment of tumorinduced osteomalacia TIO; UX007 in Phase 3 for patients with Glut1 DS; UX007 as an oral administration in Phase 2 for the treatment of LCFAOD. DTX301, in Phase 2 for the treatment of ornithine transcarbamylase OTC deficiency; DTX401 in Phase 1 for the treatment of GSDIa, and DTX201 in Phase 1 for the treatment of hemophilia A. It works in partnership with various academic institutes and biotechnology companies to advance its product candidates. Ultragenyx is headquartered in Novato, California, the US.


Ultragenyx Pharmaceutical Inc RARE Medical Equipment Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions.


GlobalData derived the data presented in this report from proprietary inhouse Medical eTrack deals database, and primary and secondary research.


Scope


Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector.

Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios.

Business Description A brief description of the company's operations.

Key Employees A list of the key executives of the company.

Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors A list of the key competitors of the company.

Key Recent Developments A brief on recent news about the company.


Reasons to Buy


Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.


Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.


Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.


Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.


Stay uptodate on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.


Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.


Note*: Some sections may be missing if data is unavailable for the company.

Original Article: Ultragenyx Pharmaceutical Inc RARE Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

NEXT ARTICLE

More From BioPortfolio on "Ultragenyx Pharmaceutical Inc RARE Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...